Orthofix Medical (OFIX)
(Delayed Data from NSDQ)
$16.14 USD
+0.33 (2.09%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $16.26 +0.12 (0.74%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OFIX 16.14 +0.33(2.09%)
Will OFIX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for OFIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OFIX
Orthofix Medical's (OFIX) Fitbone System Gets FDA Clearance
Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance
OFIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Avanos Medical (AVNS) Q1 Earnings Beat Estimates (Revised)
Avanos Medical (AVNS) Q1 Earnings Lag Estimates
Orthofix (OFIX) Q4 Earnings Beat Estimates, Gross Margin Up
Other News for OFIX
Orthofix Names Stephanie Walsh Chief Human Resources Officer
Orthofix appoints Stephanie Walsh as chief human resources officer
Orthofix to Report Second Quarter 2024 Financial Results
Orthofix Announces 510(k) Clearance and First Implant of Fitbone Transport and Lengthening System
Orthofix Medical Breaks Above 200-Day Moving Average - Bullish for OFIX